Muthoot Microfin Surges on Growth, Analysts See 15% Upside Despite Losses

BANKINGFINANCE
Whalesbook Logo
AuthorAnanya Iyer|Published at:
Muthoot Microfin Surges on Growth, Analysts See 15% Upside Despite Losses
Overview

Muthoot Microfin (MML) has exceeded its FY26 asset under management (AUM) growth targets with a 13% increase, showing a strong recovery after FY25 challenges. Diversification into individual loans and Micro-Loan Against Property (Micro-LAP) is reshaping its portfolio. Despite a stock price around ₹189 and a market cap near ₹3,200 crore, the company's trailing twelve-month earnings are negative, creating a valuation puzzle compared to profitable peers like CreditAccess Grameen. Analysts maintain a 'Strong Buy' rating with price targets suggesting considerable upside, banking on asset quality improvements and its book value multiple.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Growth Rebounds, Diversification Picks Up Pace

Muthoot Microfin has achieved a significant rebound in its asset under management (AUM), increasing by 13% year-on-year to ₹14,006 crore. This performance surpasses its initial FY26 guidance. The accelerated growth, driven by a steady increase in loan disbursements, indicates the company has navigated the sector-wide pressures faced in FY25. Muthoot Microfin's strategic expansion into new products such as individual loans, Micro-Loan Against Property (Micro-LAP), and gold loans is yielding positive results. The proportion of non-Joint Liability Group (JLG) products in its portfolio has risen sharply to 17%, from just 3% a year ago. This shift reflects a move towards a more varied and potentially stable revenue base. The company's stock currently trades around ₹189-₹194, with a market capitalization near ₹3,200-₹3,300 crore. Collection efficiency stood at 96.43% in Q4 FY26, supporting an optimistic outlook.

Valuation Puzzle: Discount vs. Peers Amid Sector Recovery

The microfinance sector is recovering after experiencing high delinquencies in FY25, partly due to excessive lending and borrower over-leverage. Muthoot Microfin currently trades at about 1.1 times its estimated FY28 book value. This represents a notable discount compared to its larger peer, CreditAccess Grameen (CAGL), which trades at approximately 2.2 times its estimated FY28 book value. This valuation gap is significant, especially given CAGL's stronger profitability and market position. However, Muthoot Microfin's stock has performed well recently, gaining over 40% in the past year, outperforming broader market indices. CRISIL has upgraded MML's outlook to 'positive' and reaffirmed its 'A+' rating, citing improved collections and sufficient provisioning, despite ongoing asset quality challenges. The potential for sector consolidation, especially if strategic deals involving companies like CAGL occur, could help lift valuations for firms like MML. Analysts generally rate the stock as a 'Strong Buy' with an average price target of ₹217.50, suggesting potential upside of over 15%.

Concerns Remain: Negative Earnings and Leverage Risks

Despite the positive growth narrative and valuation discount, Muthoot Microfin faces a significant concern: its trailing twelve-month earnings are negative, meaning it incurred losses over the past year. This contrasts sharply with profitable peers like CreditAccess Grameen, which trades at a P/E ratio of over 40x. While the company's stock trades below its book value, suggesting a potential value trap for some investors, its Return on Equity (ROE) has also been deeply negative, around -8.19% to -10.59%. Although credit costs have fallen significantly from 9.4% in FY25 to 3.5% in FY26, and the company targets a Return on Assets (ROA) of 2% for FY26, these figures are a notable improvement from a loss-making FY25 and a modest 0.5% in H1 FY26. The microfinance sector has a history of over-lending and borrower over-indebtedness, risks MML itself encountered, leading to past financial stress. Additionally, MML's debt is not fully covered by its operating cash flow, and operating expenses remain high due to collection incentives. These factors could limit margin growth in the short term. The success of its diversification into newer, potentially riskier products will be crucial and could face challenges from competition and regulatory oversight.

Future Outlook: Diversification and Growth Targets

Muthoot Microfin's management has set ambitious targets for FY27, projecting 20% AUM growth to reach ₹17,000 crore. The company aims for its loan portfolio to consist of 70% JLG and 30% non-JLG products by the end of the fiscal year. Muthoot Microfin expects further improvements in Net Interest Margins (NIMs) due to a lower cost of funds and optimized portfolio yields. Credit costs are forecast to remain manageable, potentially dropping to between 2.25% and 2.5% in FY27. The recent 'positive' rating outlook from CRISIL and the 'Strong Buy' consensus from analysts, with an average price target of ₹217.50, indicate strong confidence in the company's turnaround potential and its ability to use diversification to achieve sustained profitability and create shareholder value.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.